Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

Five Critical Steps for Successfully Leveraging AI

Posted by Arun Shastri on Fri, Apr 27, 2018

Dharmendra Sahay co-wrote this blog post with Arun Shastri.

This post is the first in a two-part series.

In a few days, we’ll be presenting our thoughts on how to create impact with artificial intelligence at the 2018 PMSA Annual Conference. We’ll talk about how AI is being used in life sciences and how AI could be used, and we’ll bust some myths. We’ll also share detailed advice on how to start or expand an AI capability at your organization, which includes these five critical steps:

Read More

Topics: data science, data and analytics, analytics disruption, pharma companies, artificial intelligence & pharma, advanced analytics, PMSA 2018

The Next Challenge in Realizing Customer Centricity

Posted by Pete Mehr on Tue, Apr 03, 2018

This post is the first in a three-part series on how pharma companies can achieve customer centricity.

“I know what to do, I just can’t do it.” 

Sound familiar? Most life sciences companies have made, and continue to make, significant investments in digital promotion tactics, digital data, cloud-based customer databases, machine learning and artificial intelligence. These investments have enabled companies to capture more customer information, develop new and better insights into customer preferences, and obtain these insights faster than ever before. These new capabilities enable life sciences companies to take actions to better meet customer needs, delivering content via tactics at the optimal time. 

Read More

Topics: technology, customers, customer centricity, Analytics, data science, customer journey, insights, marketing automation tools, machine learning, pharma marketing, data and analytics, orchestrated marketing, trigger marketing, tactic-based marketing, customer-centric pharma organizations

The State of the Union Between Pharma and Tech

Posted by Vickye Jain on Tue, Jan 09, 2018

Sandeep Varma and Raghav Sharma co-wrote this blog post with Vickye Jain.

Pharmaceutical companies have a reputation for lagging behind other industries when it comes to technology, but that reputation now seems unwarranted in many respects. As technology professionals who work with pharmaceutical clients, we feel an obligation not only to share how pharma is innovating, but also to bring those innovations back to pharma. At two recent industry events, the Strata Data Conference in Singapore and the Spark Summit in Ireland, we learned a great deal from the presentations that we attended, and almost just as much from the audience’s reaction to our own presentations. Here are our top three takeaways from these conferences:

Read More

Topics: technology, data, Pharmaceutical Companies, data science, pharmaceuticals, manufacturers, technology innovation, machine learning, artificial intelligence & pharma, Spark Summit, Strata Data Conference, DevOps

Subscribe to The Active Ingredient
SUBSCRIBE

Get 'THE ACTIVE INGREDIENT' Updates

Subscribe to receive email notifications whenever new blog posts are published.

×